Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS)

被引:8
作者
Solmaz, Dilek [1 ]
Yildirim, Tulay [2 ]
Avci, Okan [1 ]
Tomas, Nazmiye [3 ]
Akar, Servet [4 ]
机构
[1] Namik Kemal Univ Hosp, Div Rheumatol, Dept Internal Med, Fac Med, Tekirdag, Turkey
[2] Namik Kemal Univ Hosp, Dept Physiotherapy & Rehabil, Fac Med, Tekirdag, Turkey
[3] Izmir Katip Celebi Univ, Izmir Ataturk Res & Training Hosp, Izmir, Turkey
[4] Izmir Katip Celebi Univ, Div Rheumatol, Dept Internal Med, Sch Med, Izmir, Turkey
关键词
Disease activity; Simplified version of the ASDAS (SASDAS); AXIAL SPONDYLOARTHRITIS; ASDAS; BASDAI; VALIDITY; CRITERIA; THERAPY;
D O I
10.1007/s10067-015-3147-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Various types of disease activity measures are available for axial spondyloarthritis (axSpA), and there is no gold standard for all individual patients. The ankylosing spondylitis disease activity score (ASDAS) is highly discriminatory, sensitive to change, and associated with structural progression. A simplified version of the ASDAS (SASDAS) was proposed and found to be a simple and practical tool to assess disease activity. Our aim was to test the performance characteristics of the SASDAS and compare it with validated tools. In total, 97 consecutive ankylosing spondylitis (AS) patients were included in the study. Disease activity was assessed by the ASDAS-erythrocyte sedimentation rate (ESR), ASDAS-C-reactive protein (CRP), bath ankylosing spondylitis disease activity index (BASDAI), and SASDAS. The relationship among these activity indices and the level of agreement of various activity categories were tested. There was a strong correlation between the SASDAS and other activity indices, including the BASDAI (r = 0.916, p < 0.001), ASDAS-CRP (r = 0.847, p < 0.001), and ASDAS-ESR (r = 0.942, p < 0.001). Although the agreement between the ASDAS-ESR and SASDAS was good (weighted kappa of 0.744 and total agreement of 77 %), there was moderate agreement between the ASDAS-CRP and SASDAS (weighted kappa of 0.579 and total agreement of 66 %). The disagreement was particularly striking in "moderate" and "high disease activity" states. Approximately 40 % of patients classified as moderate activity according to the ASDAS-ESR and 45 % according to the ASDAS-CRP were differentially categorized by the SASDAS. The results of the present analysis suggest that the simplified version of the ASDAS-ESR should be further validated in various settings and populations due to a questionable level of agreement between the ASDAS-CRP and SASDAS.
引用
收藏
页码:1753 / 1758
页数:6
相关论文
共 50 条
[31]   Evaluation of a French version of the bath ankylosing spondylitis disease activity index in patients with spondyloarthropathy [J].
Claudepierre, P ;
Sibilia, T ;
Goupille, P ;
Flipo, RM ;
Wendling, D ;
Eulry, F ;
Clerc, D ;
Berthelot, JM ;
Vergne, P ;
RoudotThoraval, F ;
LargetPiet, B ;
Chevalier, X .
JOURNAL OF RHEUMATOLOGY, 1997, 24 (10) :1954-1958
[32]   Performance of the Ankylosing Spondylitis Disease Activity Score based on a quick quantitative C-reactive protein assay in patients with axial spondyloarthritis [J].
Proft, Fabian ;
Muche, Burkhard ;
Spiller, Laura ;
Rodriguez, Valeria Rios ;
Rademacher, Judith ;
Weber, Anne-Katrin ;
Lueders, Susanne ;
Protopopov, Mikhail ;
Redeker, Imke ;
Spiller, Inge ;
Sieper, Joachim ;
Poddubnyy, Denis .
JOINT BONE SPINE, 2020, 87 (01) :69-73
[34]   Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Global Score (BASG) [J].
El Miedany, Yasser ;
Youssef, Sally ;
Mehanna, Annie ;
Shebrya, Naglaa ;
Abu Gamra, Sherif ;
El Gaafary, Maha .
CLINICAL RHEUMATOLOGY, 2008, 27 (05) :605-612
[35]   Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Global score (BASG) [J].
Yasser El Miedany ;
Sally Youssef ;
Annie Mehanna ;
Naglaa Shebrya ;
Sherif Abu Gamra ;
Maha El Gaafary .
Clinical Rheumatology, 2008, 27 :605-612
[36]   Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis [J].
Lukas, C. ;
Landewe, R. ;
Sieper, J. ;
Dougados, M. ;
Davis, J. ;
Braun, J. ;
van der Linden, S. ;
van der Heijde, D. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (01) :18-24
[37]   A NEW APPROACH TO DEFINING DISEASE STATUS IN ANKYLOSING-SPONDYLITIS - THE BATH ANKYLOSING-SPONDYLITIS DISEASE-ACTIVITY INDEX [J].
GARRETT, S ;
JENKINSON, T ;
KENNEDY, LG ;
WHITELOCK, H ;
GAISFORD, P ;
CALIN, A .
JOURNAL OF RHEUMATOLOGY, 1994, 21 (12) :2286-2291
[38]   Serum sclerostin as a biomarker of disease activity in ankylosing spondylitis in correlation with radiographic imaging [J].
Sakrana, Nouran Medhat Abd El Samad ;
Badr, Nevine Mohamed ElSayed ;
Hassan, Manar Ahmed Azab ;
Hassan, Marwa Ahmed Kamel .
EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2024, 51 (01)
[39]   Posttraumatic stress disorder and correlates of disease activity among veterans with ankylosing spondylitis [J].
Liew, Jean ;
Williams, J. Lucas ;
Dobscha, Steven ;
Barton, Jennifer L. .
RHEUMATOLOGY INTERNATIONAL, 2017, 37 (10) :1765-1769
[40]   Frequency and characteristics of disease flares in ankylosing spondylitis [J].
Cooksey, Roxanne ;
Brophy, Sinead ;
Gravenor, Mike B. ;
Brooks, Caroline J. ;
Burrows, Claire L. ;
Siebert, Stefan .
RHEUMATOLOGY, 2010, 49 (05) :929-932